期刊文献+

大鼠外翻肠囊法考察对乙酰氨基酚的渗透性 被引量:5

Study on the permeability of Acetaminophen by rat isolated everted gut sacs
原文传递
导出
摘要 目的采用大鼠外翻肠囊模型,考察对乙酰氨基酚的渗透性。方法以大鼠外翻肠囊为模型,用HPLC法测定对乙酰氨基酚在不同肠段的透过量(Q),计算吸收速率常数(Ka)和表观渗透系数(P_(app)),评价对乙酰氨基酚在不同肠段的渗透性。结果所有组别的P_(app)值均大于高渗模型药物的P_(app)值,且不同肠段、不同给药浓度的Papp测定结果均无显著性差异。结论高、中、低浓度对乙酰氨基酚的渗透性无显著性差异;且不同肠段的渗透性无显著性差异;对乙酰氨基酚在大鼠外翻肠囊模型上表现为高渗透性。 OBJECTIVE To determine the permeability of Acetaminophen at different concentrations by everted intestinal sacs model of rat.METHODS The everted gut sacs was used to study the permeability of Acetaminophen by K)a and Papp in different segments of rat intestines(duodenum,jejunum,ileum).The samples were collected at different time and determined with HPLC.RESULTS The Papp in all groups was more than 1×10-6 cm·s-1 along without statistically significant difference in the results of different intestine segments and concentrations,which indicated that permeability of Acetaminophen in intestine was high.CONCLUSION The absorption of Acetaminophen in different intestinal segments is high.
作者 周雪 许毓骢 汪忠军 王南男 邓黎 贺英菊 ZHOU Xue;XU Yucong;WANG Zhongjun;WANG Nannan;DENG Li;HE Yingu(West China School of Pharmacy,Sichuan University,Chengdu,Sichuan,610041 P.R.China)
出处 《华西药学杂志》 CAS CSCD 2019年第2期157-160,共4页 West China Journal of Pharmaceutical Sciences
关键词 对乙酰氨基酚 外翻肠囊法 表观渗透系数 吸收速率常数 渗透性 高效液相色谱法 Acetaminophen Everted gut sacs method Papp Ka Permeability HPLC
  • 相关文献

参考文献5

二级参考文献19

  • 1田怀平,马小亚,王美纳.奥硝唑在兔体内的药动学和生物利用度研究[J].西北药学杂志,2005,20(3):104-106. 被引量:3
  • 2陈燕,石涛,柳晓泉,钟皎,王广基.左旋和右旋奥硝唑在大鼠体内的药代动力学[J].中国药科大学学报,2006,37(1):41-44. 被引量:14
  • 3陈忆冰,李健和,黎银波,彭六保.左旋奥硝唑氯化钠注射液细菌内毒素检查[J].西北药学杂志,2007,22(3):141-142. 被引量:4
  • 4Barthe L, Woodley J, Houin G. Gastrointestinal absorption of drugs:methods and studies [ J]. Fundam Clin Pharmacol, 1999, 13(2) :154.
  • 5Kilic F S, Batu O, Sirmagul B, et al. Intestinal absorption of digoxin and interaction with nimodipine in rats [ J ]. Pol J Pharmacol, 2004,56 : 137.
  • 6CHOI J S,PIAO Y J,KANG K W.Effects of quercetin on the bioavailability of doxorubicin in rats:role of CYP3A4 and P-gp inhibition by quercetin[J].Arch Pharm Res,2011,34(4):607-613.
  • 7TACHIBANA T,KATO M,WATANABE T,et al.Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein[J].Xenobiotica,2009,39(6):430-443.
  • 8TACHIBANA T,KATO M,TAKANO J,et al.Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein[J].Curr Drug Metab,2010,11(9):762-772.
  • 9MACLEAN C,MOENNING U,REICHEL A,et al.Closing the gaps:a full scan of the intestinal expression of P-glycoprotein,breast cancer resistance protein,and multidrug resistance-associated protein 2 in male and female rats[J].Drug Metab Dispos,2008,36(7):1249-1254.
  • 10盖文婷,朱连勤,朱风华,孙金全,曲韵笙.离体肉鸡小肠对纳米氧化铜吸收速率的研究[J].中国饲料,2008(9):32-34. 被引量:9

共引文献35

同被引文献18

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部